Measles Virus Vaccine Live Attenuated

From Anvita Health Wiki

Contents 1 Indications 2 Contraindications 3 Dosage 4 Adverse-effects 5 Test-interactions 6 More General Terms 7 Additional Terms 8 References

Indications

• immunization against measles ( rubeola) in patients > 15 months of age

Contraindications

• hypersensitivity to eggs
• hypersensitivity to neomycin
• pregnancy

• Caution:

• history of febrile seizures
• females should avoid pregnancy for 3 months afer vaccination
• defer vaccination for 3 months following plasma transfusions or administration of immune globulin or immunosuppressive drugs

Dosage

• Children > 15 months & adults: 0.5 mL SC
• Injection: 1000 TCID50 per dose

Adverse-effects

• common (> 10%)

• fever < 100 F
• burning at site of injection

• less common (1-10%)

• fever 100-103 F, delayed-type allergic reaction

• uncommon (< 1%)

• difficulty breathing, hives, itching, reddening of skin (especially around eyes & ears), tiredness, convulsions, encephalitis, confusion, severe headache, stiff neck, vomiting, diplopia, thrombocytopenic purpura, prolonged fever > 103 F, lymphadenopathy Vaccine interactions:
• should not be given within 1 month of other live virus vaccines except monovalent or trivalent polio vaccine

Test-interactions

• temporary suppression of TB skin test reactivity

More General Terms

• vaccine

Additional Terms

• measles & rubella combined vaccine (M-R-VAX II)
• measles (1st disease)
• measles virus (rubeola)
• measles, mumps & rubella combined vaccine (MMR)

References

Kaiser Permanente Northern California Regional Drug  Formulary, 1998

measles virus vaccine, live, attenuated (Attenuvax)